Peripheral and placental biomarkers in women with placental malaria: a systematic review.
Placental malaria (PM) causes significant morbidity in mothers and infants. Diagnosis of PM during pregnancy is however problematic due to placental sequestration of parasites. Host biomarkers may therefore be used as a diagnostic method. In this systematic review most studies focused on inflammatory markers. A trend was observed for increased IL-10 and TNF-α in PM positives. These markers are however unspecific, thus a combination of multiple biomarkers involved in different pathophysiological pathways of PM is indicated. Of interest are inflammatory markers (TNF-R2, CXCL-13), markers of lipid metabolism (APO-B), angiogenesis (sFlt-1) and hormones (estradiol). As the majority of published studies tested biomarker levels only at delivery, more longitudinal cohort studies will be necessary to detect biomarkers during pregnancy that can predict PM.
KIT Biomedical Research, Royal Tropical Institute (KIT), Amsterdam, The Netherlands.
Esmée
E
Ruizendaal
Elisabeth
E
van Leeuwen
Petra F
PF
Mens
D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008288:Malaria / Q000097:blood* / Q000378:metabolism*; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood* / Q000378:metabolism*
D015415:Biomarkers
Plasmodium falciparum; biomarkers; malaria; placenta malaria; pregnancy